Pure Biologics

Pure Biologics EBIT Margin

The EBIT Margin (Operating Margin) of Pure Biologics (PUR.WA) as of Nov 12, 2026 is -33,387.37 %. In the previous year, EBIT Margin (Operating Margin) was -3,720.39 % — a change of 797.42% (lower).

EBIT Margin

-33,387.37 %

YoY

797.42%

Last updated:

EBIT Margin (Operating Margin) of Pure Biologics is 2023 -33,387.37 % . EBIT Margin (Operating Margin) of Pure Biologics was 2022 -3,720.39 % . It decreases by 797.42% lower compared to the previous year.

Pure Biologics's operating (EBIT) margin stands at -33,387.4%, down from -26.1% several years earlier.

The Pure Biologics EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2016
-32.54 PLN
Jan 1, 2017
-39.34 PLN
Jan 1, 2018
-6.62 PLN
Jan 1, 2019
-26.07 PLN
Jan 1, 2020
-2,020.28 PLN
Jan 1, 2021
-4,126.77 PLN
Jan 1, 2022
-3,720.39 PLN
Jan 1, 2023
-33,387.37 PLN
The Pure Biologics EBIT Margin history
YEAREBIT MarginYoY
-33,387.37 %+797.42%
-3,720.39 %-9.85%
-4,126.77 %+104.27%
-2,020.28 %+7,650.28%
-26.07 %+293.76%
-6.62 %-83.17%
-39.34 %+20.88%
-32.54 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

EBIT Margin (Operating Margin) of Pure Biologics is -33,387.37 % in 2023.

EBIT Margin (Operating Margin) of Pure Biologics changed from -3,720.39 % to -33,387.37 %, representing a 797.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Pure Biologics with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Pure Biologics

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Pure Biologics